Transient increase in sAPPα secretion in response to Aβ1-42 oligomers: an attempt of neuronal self-defense?

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Neurobiology of Aging

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.neurobiolaging.2017.09.008PMID 29032190
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Binding Sites for Amyloid-β Oligomers and Synaptic Toxicity.

  2017cited by this paper
• The plasma membrane: Penultimate regulator of ADAM sheddase function.

  2017cited by this paper
• The Alzheimer's disease Aβ peptide binds to the anionic DMPS lipid bilayer.

  2016cited by this paper
• Phosphatidylserine exposure is required for ADAM17 sheddase function

  2016cited by this paper
• Single-Cell Detection of Secreted Aβ and sAPPα from Human IPSC-Derived Neurons and Astrocytes

  2016cited by this paper
• EGFR mediates astragaloside IV-induced Nrf2 activation to protect cortical neurons against in vitro ischemia/reperfusion damages.

  2015cited by this paper
• Aβ42 oligomers selectively disrupt neuronal calcium release.

  2015cited by this paper
• Amyloid-β Peptide Aβ3pE-42 Induces Lipid Peroxidation, Membrane Permeabilization, and Calcium Influx in Neurons*

  2015cited by this paper
• Holo-APP and G-protein-mediated signaling are required for sAPPα-induced activation of the Akt survival pathway

  2014cited by this paper
• Soluble amyloid precursor proteins and secretases as Alzheimer's disease biomarkers.

  2014cited by this paper
• Protective effects of placental growth factor on retinal neuronal cell damage

  2014cited by this paper
• Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease.

  2013cited by this paper
• SORL1 Is Genetically Associated with Late-Onset Alzheimer’s Disease in Japanese, Koreans and Caucasians

  2013cited by this paper
• Binding of β-amyloid (1-42) peptide to negatively charged phospholipid membranes in the liquid-ordered state: modeling and experimental studies.

  2012cited by this paper
• Icy: an open bioimage informatics platform for extended reproducible research

  2012cited by this paper
• New highly sensitive rodent and human tests for soluble amyloid precursor protein alpha quantification: preclinical and clinical applications in Alzheimer’s disease

  2012cited by this paper
• Clinical and neurobiological correlates of soluble amyloid precursor proteins in the cerebrospinal fluid

  2012cited by this paper
• Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures.

  2012cited by this paper
• Quantitative proteomic analysis reveals protein expression changes in the murine neuronal secretome during apoptosis.

  2012cited by this paper
• Cerebrospinal Fluid Soluble Amyloid-β Protein Precursor as a Potential Novel Biomarkers of Alzheimer's Disease

  2012cited by this paper
• Functions of Aβ, sAPPα and sAPPβ : similarities and differences

  2012cited by this paper
• The physiology of the β‐amyloid precursor protein intracellular domain AICD

  2012cited by this paper
• Activation of α‐secretase cleavage

  2012cited by this paper
• Identification and biology of α‐secretase

  2012cited by this paper
• Cerebrospinal Fluid Levels of sAPPα and sAPPβ in Lewy Body and Alzheimer's Disease: Clinical and Neurochemical Correlates

  2011cited by this paper
• PAT1 induces cell death signal and SET mislocalization into the cytoplasm by increasing APP/APLP2 at the cell surface.

  2011cited by this paper
• Neuroprotection of midbrain dopamine neurons by nicotine is gated by cytoplasmic Ca2+

  2011cited by this paper
• Secreted Amyloid Precursor Protein β and Secreted Amyloid Precursor Protein α Induce Axon Outgrowth In Vitro through Egr1 Signaling Pathway

  2011cited by this paper
• Meta-analysis of the association between variants in SORL1 and Alzheimer disease.

  2011cited by this paper
• Aberrant subcellular neuronal calcium regulation in aging and Alzheimer's disease.

  2011cited by this paper
• Calcium Signaling and Amyloid Toxicity in Alzheimer Disease*

  2010cited by this paper
• The sortilin‐related receptor SORL1 and the amyloid cascade: a possible explanation for the concurrent elevation of CSF soluble APPα and APPβ in Alzheimer's disease

  2010cited by this paper
• Amyloid beta oligomers induce Ca2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors.

  2010cited by this paper
• Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study

  2010cited by this paper
• sAPPalpha antagonizes dendritic degeneration and neuron death triggered by proteasomal stress.

  2010cited by this paper
• ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor alpha, L-selectin, and tumor necrosis factor alpha.

  2009cited by this paper
• SORL1 is genetically associated with Alzheimer disease in a Japanese population.

  2009cited by this paper
• SORL1 is genetically associated with increased risk for late‐onset Alzheimer disease in the Belgian population

  2008cited by this paper
• VPS10P-domain receptors — regulators of neuronal viability and function

  2008cited by this paper
• The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease

  2007cited by this paper
• ADAM19 is tightly associated with constitutive Alzheimer's disease APP alpha-secretase in A172 cells.

  2007cited by this paper
• ADAM19 is tightly associated with constitutive alzheimer's disease APP α-secretase in A172 cells

  2007cited by this paper
• Susceptibility of hippocampal neurons to Abeta peptide toxicity is associated with perturbation of Ca2+ homeostasis.

  2007cited by this paper
• Presenilin: running with scissors in the membrane.

  2007cited by this paper
• Correction for Substrate Selectivity of Epidermal Growth Factor-Receptor Ligand Sheddases and their Regulation by Phorbol Esters and Calcium Influx

  2006cited by this paper
• LR11/SorLA Expression Is Reduced in Sporadic Alzheimer Disease but not in Familial Alzheimer Disease

  2006cited by this paper
• Interaction of the Cytosolic Domains of sorLA/LR11 with the Amyloid Precursor Protein (APP) and β-Secretase β-Site APP-Cleaving Enzyme

  2006cited by this paper
• Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein.

  2005cited by this paper
• The Disintegrin ADAM9 Indirectly Contributes to the Physiological Processing of Cellular Prion by Modulating ADAM10 Activity*

  2005cited by this paper
• Surface behavior and lipid interaction of Alzheimer beta-amyloid peptide 1-42: a membrane-disrupting peptide.

  2005cited by this paper
• ADAMs: key components in EGFR signalling and development

  2005cited by this paper
• Subcellular topography of neuronal Abeta peptide in APPxPS1 transgenic mice.

  2004cited by this paper
• Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands

  2004cited by this paper
• The role of ADAM10 and ADAM17 in the ectodomain shedding of angiotensin converting enzyme and the amyloid precursor protein.

  2004cited by this paper
• ADAMs family members as amyloid precursor protein alpha-secretases.

  2003cited by this paper
• Putative function of ADAM9, ADAM10, and ADAM17 as APP -secretase

  2003cited by this paper
• Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase.

  2003cited by this paper
• ADAMs family members as amyloid precursor protein α‐secretases

  2003cited by this paper
• A secreted form of human ADAM9 has an alpha-secretase activity for APP.

  2002cited by this paper
• Abeta toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets.

  2002cited by this paper
• A secreted form of human ADAM9 has an α-secretase activity for APP☆

  2002cited by this paper
• Alzheimer's disease: genes, proteins, and therapy.

  2001cited by this paper
• Processing of Amyloid Precursor Protein in Human Primary Neuron and Astrocyte Cultures

  1997cited by this paper
• Fusogenic Properties of the C-terminal Domain of the Alzheimer β-Amyloid Peptide*

  1996cited by this paper
• Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum.

  1993cited by this paper
• In vitro control of neuronal polarity by glycosaminoglycans.

  1992cited by this paper

• Plasma amyloid beta predicts conversion to dementia in subjects with mild cognitive impairment: The BALTAZAR study

  2022cites this paper
• The Challenge of Gene Therapy for Neurological Diseases: Strategies and Tools to Achieve Efficient Delivery to the Central Nervous System

  2020cites this paper
• Metalloproteinases and their tissue inhibitors in Alzheimer’s disease and other neurodegenerative disorders

  2019cites this paper
• Emerging Alternative Proteinases in APP Metabolism and Alzheimer’s Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP

  2019cites this paper
• Fragile X and APP: a Decade in Review, a Vision for the Future

  2018cites this paper
• Proamyloidogenic effects of membrane type 1 matrix metalloproteinase involve MMP‐2 and BACE‐1 activities, and the modulation of APP trafficking

  2018cites this paper